These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6521858)

  • 1. Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover.
    Roth BL; Nakaki T; Chuang DM; Costa E
    Neuropharmacology; 1984 Oct; 23(10):1223-5. PubMed ID: 6521858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.
    Roth BL; Nakaki T; Chuang DM; Costa E
    J Pharmacol Exp Ther; 1986 Aug; 238(2):480-5. PubMed ID: 3016238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.
    Conn PJ; Sanders-Bush E
    Neuropharmacology; 1984 Aug; 23(8):993-6. PubMed ID: 6483122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction: participation of Ca++ channels and phospholipase C.
    Nakaki T; Roth BL; Chuang DM; Costa E
    J Pharmacol Exp Ther; 1985 Aug; 234(2):442-6. PubMed ID: 2410594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Neuropharmacology; 1983 Jan; 22(1):123-6. PubMed ID: 6843781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential large and small vessel responses to serotonin in the dog hindlimb in vivo: role of the 5HT2 receptor.
    Blackshear JL; Orlandi C; Garnic JD; Hollenberg NK
    J Cardiovasc Pharmacol; 1985; 7(1):42-9. PubMed ID: 2580149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletion.
    Cussac D; Newman-Tancredi A; Quentric Y; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):221-3. PubMed ID: 10685880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
    Conn PJ; Sanders-Bush E; Hoffman BJ; Hartig PR
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4086-8. PubMed ID: 2940597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA; Schutz LJ
    J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism.
    Parrish JC; Nichols DE
    J Neurochem; 2006 Nov; 99(4):1164-75. PubMed ID: 17010161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic, adrenergic and histaminergic receptors coupled to phospholipase C in cultured cerebellar granule cells of rats.
    Xu J; Chuang DM
    Biochem Pharmacol; 1987 Jul; 36(14):2353-8. PubMed ID: 3038121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycholate induces the preferential hydrolysis of polyphosphoinositides by human platelet and rat corneal phospholipase C.
    Chung SM; Proia AD; Klintworth GK; Watson SP; Lapetina EG
    Biochem Biophys Res Commun; 1985 Jun; 129(2):411-6. PubMed ID: 2990455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine receptor-mediated phosphoinositide hydrolysis in canine cultured tracheal smooth muscle cells.
    Yang CM; Yo YL; Hsieh JT; Ong R
    Br J Pharmacol; 1994 Mar; 111(3):777-86. PubMed ID: 8019756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyphosphoinositide hydrolysis by phospholipase C is accelerated by thyrotropin releasing hormone (TRH) in clonal rat pituitary cells (GH3 cells).
    Schlegel W; Roduit C; Zahnd GR
    FEBS Lett; 1984 Mar; 168(1):54-60. PubMed ID: 6323219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling.
    McKune CM; Watts SW
    J Pharmacol Exp Ther; 2001 Apr; 297(1):88-95. PubMed ID: 11259531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine induces phospholipase C-mediated hydrolysis of phosphoinositides through 5-hydroxytryptamine-2 receptors in cultured fetal mouse ventricular myocytes.
    Hamamori Y; Yokoyama M; Yamada M; Akita H; Goshima K; Fukuzaki H
    Circ Res; 1990 Jun; 66(6):1474-83. PubMed ID: 2160868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
    Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
    J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.